Sandoz Group AG
Abierto
67.02 -0.12
Resumen
Variación precio
24h
Mínimo
66.52
Máximo
67.9
Ingresos | 160M 537M |
|---|---|
Ventas | 641M 5.9B |
P/B Media del Sector | 38.795 49.052 |
BPA | 1.238 |
Rentabilidad por dividendo | 1.59 |
Margen de beneficios | 9.093 |
Empleados | 22,356 |
EBITDA | 427M 1B |
Recomendaciones | Comprar |
|---|---|
Estimación a 12 Meses | +10.39% upside |
Rentabilidad por dividendo Media del Sector | 1.59% 2.36% |
|---|---|
Próximas Ganancias | 5 ago 2026 |
Capitalización Mercado | -1.1B 28B |
|---|---|
Apertura anterior | 67.14 |
Cierre anterior | 67.02 |
Sandoz Group AG Gráfico
Resultados pasados no son un indicador fiable de resultados futuros.
Acerca de Sandoz Group AG
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland.
